Showing results (1711-1720 of 1,914) with videos related to

Sort By:
Pageof 192
British Journal of Cancer|December 30, 2023
Targeting serine/glycine metabolism improves radiotherapy response in non-small cell lung cancerAnaís Sánchez-Castillo, Elien Heylen, Judith Hounjet, et al.
Molecular Cancer Research : MCR|June 24, 2022
Distinct Transcriptional Programs in Ascitic and Solid Cancer Cells Induce Different Responses to Chemotherapy in High-Grade Serous Ovarian CancerNele Loret, Niels Vandamme, Jordy De Coninck, et al.
Water Environment Research : a Research Publication of the Water Environment Federation|August 13, 2019
Survey of full-scale sidestream enhanced biological phosphorus removal (S2EBPR) systems and comparison with conventional EBPRs in North America: Process stability, kinetics, and microbial populationsAnnalisa Onnis-Hayden, Varun Srinivasan, Nicholas B Tooker, et al.
Functional & Integrative Genomics|November 22, 2002
TAIR: a resource for integrated Arabidopsis dataMargarita Garcia-Hernandez, Tanya Z Berardini, Guanghong Chen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 13, 2023
Outcome of Biological Therapies and Small Molecules in Ulcerative Proctitis: A Belgian Multicenter Cohort StudyPauline Lemmens, Edouard Louis, Wouter Van Moerkercke, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 14, 2020
Progression-Free and Overall Survival for Concurrent Nivolumab With Standard Concurrent Chemoradiotherapy in Locally Advanced Stage IIIA-B NSCLC: Results From the European Thoracic Oncology Platform NICOLAS Phase II Trial (European Thoracic Oncology Platform 6-14)Solange Peters, Enriqueta Felip, Urania Dafni, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 27, 2023
18F-FDG-PET guided vs whole tumour radiotherapy dose escalation in patients with locally advanced non-small cell lung cancer (PET-Boost): Results from a randomised clinical trialSaskia A Cooke, Dirk de Ruysscher, Bart Reymen, et al.
Clinical Chemistry|January 28, 2026
PIDgeon: An Explainable AI Model for Improved Flow Cytometry-Based Screening of Lymphoid Primary ImmunodeficienciesAnnelies Emmaneel, Jana Neirinck, Alba Torres-Valle, et al.
NPJ Digital Medicine|June 16, 2025
Exploratory digital outcome measures of motor sign progression in Parkinson's disease patients treated with prasinezumabKirsten I Taylor, Florian Lipsmeier, Marzia A Scelsi, et al.
Frontiers in Immunology|December 17, 2020
Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19Karel F A Van Damme, Simon Tavernier, Nele Van Roy, et al.
Pageof 192